BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND CCND3, P30281, 896, ENSG00000112576 AND Treatment
8 results:

  • 1. Risk-stratified Distant Metastatic thyroid cancer with Clinicopathological Factors and BRAF/TERT Promoter Mutations.
    Cheng X; Zhou Y; Xu S; Yu H; Wu J; Bao J; Zhang L
    Exp Clin Endocrinol Diabetes; 2023 Nov; 131(11):577-582. PubMed ID: 37922948
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Random Forest for Predicting treatment Response to Radioiodine and Thyrotropin Suppression Therapy in Patients With Differentiated thyroid cancer But Without Structural Disease.
    Sa R; Yang T; Zhang Z; Guan F
    Oncologist; 2024 Jan; 29(1):e68-e80. PubMed ID: 37669005
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Active surveillance is an excellent management technique for identifying patients with progressive low-risk papillary thyroid microcarcinoma requiring surgical treatment.
    Fujishima M; Miyauchi A; Ito Y; Kudo T; Noda T; Sano T; Sasaki T; Kishi T; Nakamura T
    Endocr J; 2023 Apr; 70(4):411-418. PubMed ID: 36631086
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic model for predicting overall and cancer-specific survival among patients with superficial spreading melanoma: A SEER based study.
    Ji Q; Tang J; Li S; Chen J
    Medicine (Baltimore); 2022 Dec; 101(52):e32521. PubMed ID: 36596029
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Therapeutic options in locally advanced thyroid carcinoma. Our experience.
    Avenia N; Monacelli M; Sanguinetti A; Santoprete S; Pecoriello R; Ragusa M; Puma F
    Ann Ital Chir; 2012; 83(6):481-5. PubMed ID: 22615040
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Late mortality and second cancers in an Australian cohort of childhood cancer survivors.
    Wilson CL; Cohn RJ; Johnston KA; Ashton LJ
    Med J Aust; 2010 Sep; 193(5):258-61. PubMed ID: 20819041
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Judicious use of recombinant TSH in the management of differentiated thyroid carcinoma.
    Khan MU; Nawaz MK; Shah MA; Syed AA; Khan AI
    Ann Nucl Med; 2010 Oct; 24(8):609-15. PubMed ID: 20700666
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cost-effective management of low-risk papillary thyroid carcinoma.
    Shrime MG; Goldstein DP; Seaberg RM; Sawka AM; Rotstein L; Freeman JL; Gullane PJ
    Arch Otolaryngol Head Neck Surg; 2007 Dec; 133(12):1245-53. PubMed ID: 18086967
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.